Evaluation of Saroglitazar's Effects on Small Dense LDL and Non-HDL Cholesterol Particles in Diabetic Dyslipidemia Patients

被引:0
|
作者
Dinkar, Jyoti
Ranjan, Rajeev
Chandra, Abhishek
机构
关键词
D O I
10.2337/db23-7-OR
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
7-OR
引用
收藏
页数:1
相关论文
共 50 条
  • [31] The non-hdl cholesterol to hdl cholesterol ratio is an independent predictor for poor long-term clinical outcomes in patients with target ldl cholesterol in the drug eluting stent era
    Chin, J. Y.
    Seung, K. B.
    Jang, K. Y.
    Koh, Y. S.
    Lee, J. E.
    Kim, T. S.
    Kim, J. J.
    Jang, M. O.
    Lim, S. M.
    Choi, I. J.
    EUROPEAN HEART JOURNAL, 2012, 33 : 1078 - 1078
  • [32] Substituting non-HDL cholesterol with LDL as a guide for lipid-lowering therapy increases the number of patients with indication for therapy
    Masana, Luis
    Ibarretxe, Daiana
    Heras, Mercedes
    Cabre, Anna
    Ferre, Raimon
    Merino, Jordi
    Plana, Nuria
    Girona, Josefa
    ATHEROSCLEROSIS, 2013, 226 (02) : 471 - 475
  • [33] Omega-III Fatty Acid Effectively Lowered Small Dense LDL in Patients with Diabetic Dyslipidemia
    Kim, Mi Kyung
    Suk, Ji Hye
    Kwon, Min Jung
    Lee, Sun Hee
    Kim, Duk Ku
    Rhee, Byoung Doo
    Park, Jeong Hyun
    DIABETES, 2011, 60 : A573 - A573
  • [34] High triglycerides, low HDL cholesterol, and small LDL particles: The main lipid risk factors in type 2 diabetic coronary patients
    Drexel, H.
    Aczel, S.
    Marte, T.
    Schmid, F.
    Koch, L.
    Langer, P.
    Rein, P.
    Saely, C. H.
    ATHEROSCLEROSIS SUPPLEMENTS, 2007, 8 (01) : 149 - 149
  • [35] Non-HDL cholesterol and residual risk of cardiovascular events in patients with ischemic heart disease and well-controlled LDL cholesterol: a cohort study
    Hansen, Malene Kaerslund
    Mortensen, Martin Bodtker
    Olesen, Kevin Kris Warnakula
    Thrane, Pernille Gro
    Maeng, Michael
    LANCET REGIONAL HEALTH-EUROPE, 2024, 36
  • [36] SMALL DENSE LDL CHOLESTEROL, HDL PARTICLES, INSULIN, ADIPONECTIN, AND GLYCATED ALBUMEN AS PROSPECTIVE CHD RISK FACTORS IN THE FRAMINGHAM STUDY
    Schaefer, E. J.
    Ai, M.
    Otokozawa, S.
    Asztalos, B. F.
    White, C. C.
    Demissie, S.
    Cupples, A.
    ATHEROSCLEROSIS SUPPLEMENTS, 2008, 9 (01) : 10 - 11
  • [37] Association of LDL Cholesterol, Non-HDL Cholesterol, and Apolipoprotein B Levels With Risk of Cardiovascular Events Among Patients Treated With Statins A Meta-analysis
    Boekholdt, S. Matthijs
    Arsenault, Benoit J.
    Mora, Samia
    Pedersen, Terje R.
    LaRosa, John C.
    Nestel, Paul J.
    Simes, R. John
    Durrington, Paul
    Hitman, Graham A.
    Welch, K. M. A.
    DeMicco, David A.
    Zwinderman, Aeilko H.
    Clearfield, Michael B.
    Downs, John R.
    Tonkin, Andrew M.
    Colhoun, Helen M.
    Gotto, Antonio M., Jr.
    Ridker, Paul M.
    Kastelein, John J. P.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 307 (12): : 1302 - 1309
  • [38] Elevated Non-HDL Cholesterol Levels as A Risk Factor for Diabetic Retinopathy Among Type 2 Diabetes Mellitus Patients
    Adiwinoto, R. D.
    Soelistijo, S. A.
    Pranoto, A.
    Ardiany, D.
    Widjaja, S. A.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2024, 209
  • [39] EFFECTS OF ROSUVASTATIN AND GEMFIBROZIL ON SMALL DENSE LDL-CHOLESTEROL IN CHRONIC HEMODIALYSIS PATIENTS
    Jeon, Jae Wan
    Kim, Soon Bae
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32
  • [40] Circadian change of serum concentration of small dense LDL-cholesterol in type 2 diabetic patients
    Hirayama, Satoshi
    Soda, Satoshi
    Ito, Yasuki
    Matsui, Hiroshi
    Ueno, Tsuyoshi
    Fukushima, Yoshifumi
    Ohmura, Hirotoshi
    Hanyu, Osamu
    Aizawa, Yoshifusa
    Miida, Takashi
    CLINICA CHIMICA ACTA, 2010, 411 (3-4) : 253 - 257